"Global Liver Diseases Therapeutics Market 2015-2019" is now available at Fast Market Research

Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment. The liver diseases caused by viral infections, alcoholism, obesity, diabetes, among many other reasons. Some of the diseases are not curable such as liver cirrhosis or non-alcoholic fatty liver disease, and are usually not diagnosed early. This leads to the substantial damage of the liver, which proves to be life-threatening. Some types of hepatitis are preventable or treatable by using vaccines and indicated drugs.

Technavio's analysts forecast the global liver diseases therapeutics market to grow at a CAGR of 15.61% over the period 2014-2019.

Covered in this report
This report covers the present scenario and the growth prospects of the global liver diseases therapeutics market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various off-label and branded drugs and the expected launch of drug candidates intended to be used in the treatment of liver diseases.

Full Report Details at
- http://www.fastmr.com/prod/1056003_global_liver_diseases.aspx?afid=301

Based on disease indication, the market is segmented as follows:

* Non-alcoholic fatty liver disease (includes non-alcoholic steatohepatitis)
* Liver cirrhosis
* Liver cancer
* Hepatitis (Hepatitis A, B, and C)

This report includes a discussion of the market in the following three regions:

* Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil
* EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE

* APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India.

Technavio's report, Global Liver Diseases Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the global liver diseases therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

* Americas
* APAC
* EMEA

Key vendors

* F. Hoffmann-La Roche
* Gilead Sciences
* GlaxoSmithKline
* Johnson & Johnson
* Merck

Other prominent vendors

* AbbVie
* Achillion Pharmaceuticals
* Advinus
* Angion Biomedica
* AstraZeneca
* Bayer
* BiOrion
* Boehringer Ingelheim
* Bristol-Myers Squibb
* Celsion
* Conatus
* Digna Biotech
* Dynavax Technologies
* Eli Lilly
* Galectin Therapeutics
* Genfit

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Liver Fibrosis Global Clinical Trials Review, H1, 2015
- Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015
- Chronic Liver Disease Global Clinical Trials Review, H1, 2015
- Esophageal Diseases Global Clinical Trials Review, H1, 2015
- Hepatitis C Global Clinical Trials Review, H2, 2014